Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomized, placebo controlled, multicenter study (Iressa Survival Evaluation in Lung Cancer). - Thatcher,N.; Chang,A.; Parikh,P. (Lancet, 2005)